IL287261A - Compounds and methods for detecting analytes using bioluminescence - Google Patents
Compounds and methods for detecting analytes using bioluminescenceInfo
- Publication number
- IL287261A IL287261A IL287261A IL28726121A IL287261A IL 287261 A IL287261 A IL 287261A IL 287261 A IL287261 A IL 287261A IL 28726121 A IL28726121 A IL 28726121A IL 287261 A IL287261 A IL 287261A
- Authority
- IL
- Israel
- Prior art keywords
- bioluminescence
- compositions
- methods
- analyte detection
- analyte
- Prior art date
Links
- 239000012491 analyte Substances 0.000 title 1
- 230000029918 bioluminescence Effects 0.000 title 1
- 238000005415 bioluminescence Methods 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
- C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
- C12Y113/12007—Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) (1.13.12.7), i.e. firefly-luciferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/103—Nucleic acid detection characterized by the use of physical, structural and functional properties luminescence
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962832052P | 2019-04-10 | 2019-04-10 | |
| PCT/US2020/027711 WO2020210658A1 (en) | 2019-04-10 | 2020-04-10 | Compositions and methods for analyte detection using bioluminescence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL287261A true IL287261A (en) | 2021-12-01 |
Family
ID=72751365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL287261A IL287261A (en) | 2019-04-10 | 2021-10-07 | Compounds and methods for detecting analytes using bioluminescence |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20200386748A1 (https=) |
| EP (1) | EP3953374A4 (https=) |
| JP (2) | JP7645812B2 (https=) |
| KR (1) | KR20220007058A (https=) |
| CN (1) | CN113891895A (https=) |
| AU (2) | AU2020272037B2 (https=) |
| BR (1) | BR112021020354A2 (https=) |
| CA (1) | CA3135195A1 (https=) |
| IL (1) | IL287261A (https=) |
| SG (1) | SG11202110773RA (https=) |
| WO (1) | WO2020210658A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3395803A1 (en) | 2017-04-28 | 2018-10-31 | Institut Pasteur | Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins |
| CA3158729A1 (en) * | 2019-11-27 | 2021-06-03 | Virginia Kincaid | Multipartite luciferase peptides and polypeptides |
| US12606863B2 (en) | 2021-05-13 | 2026-04-21 | Promega Corporation | Bioluminescent detection of DNA synthesis |
| WO2023028175A1 (en) * | 2021-08-24 | 2023-03-02 | Kaya17 Inc. | System and method for detecting presence of a target bioparticle in a sample via a vertical flow assay |
| CN113786873B (zh) * | 2021-08-31 | 2022-09-23 | 广西横县张一元饮品有限公司 | 一种用于食品安全检测的试管 |
| EP4411377A4 (en) * | 2021-09-29 | 2024-12-04 | FUJIFILM Corporation | Immunochromatography kit and testing device |
| CN114231401B (zh) * | 2022-02-21 | 2022-05-03 | 北京芯迈微生物技术有限公司 | 一种核酸检测试剂盒及检测方法 |
| WO2023200703A1 (en) * | 2022-04-15 | 2023-10-19 | Siemens Healthcare Diagnostics Inc. | Creatinine lateral flow assay devices and methods of production and use thereof |
| GB2619059A (en) * | 2022-05-26 | 2023-11-29 | Univ Leeds Innovations Ltd | Split reporter complex |
| EP4597108A4 (en) * | 2022-09-26 | 2026-01-14 | Fujifilm Corp | IMMUNOCHROMATOGRAPHIC CARTRIDGE |
| TR2022019556A2 (tr) * | 2022-12-16 | 2023-01-23 | Duezce Ueniversitesi Rektoerluegue Strateji Gelistirme Daire Baskanligi | Zehi̇rli̇ mantarlarin ve mantar zehi̇rlenmeleri̇ni̇n teşhi̇si̇ne olanak sağlayan halusi̇nojeni̇k etki̇ye sahi̇p psi̇losi̇bi̇n molekülü i̇çi̇n bi̇r kart testi̇ |
| CN116218907B (zh) * | 2023-02-20 | 2025-04-22 | 复旦大学附属中山医院 | 带有HiBiT新型报告基因的肠道病毒感染性克隆及其构建方法和应用 |
| EP4695346A1 (en) * | 2023-04-12 | 2026-02-18 | Promega Corporation | Poloxamer-stabilized reagents |
| WO2025024530A1 (en) * | 2023-07-25 | 2025-01-30 | The General Hospital Corporation | Aldehyde binding optical imaging probes methods of use thereof |
| CN118033130B (zh) * | 2024-01-19 | 2024-07-30 | 武汉科技大学 | 同时检测艾滋病、梅毒和丙肝的表面、微孔板、组件、方法及应用 |
| CN118255903B (zh) * | 2024-05-07 | 2025-03-11 | 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) | 一种检测非洲猪瘟病毒抗体的融合抗原、制备方法及检测试剂盒 |
| CN118344492B (zh) * | 2024-05-07 | 2025-03-11 | 中国农业科学院兰州兽医研究所(中国动物卫生与流行病学中心兰州分中心) | 一种纳米荧光素酶融合抗原在非洲猪瘟病毒抗体检测中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3423290A (en) * | 1966-08-03 | 1969-01-21 | Nasa | Lyophilized reaction mixtures |
| US6045254A (en) * | 1996-12-26 | 2000-04-04 | M.L.I.S. Projects Ltd. | Container having two or more compartments |
| US7118878B1 (en) * | 2000-06-09 | 2006-10-10 | Promega Corporation | Method for increasing luminescence assay sensitivity |
| JP4485470B2 (ja) * | 2002-12-23 | 2010-06-23 | プロメガ コーポレイション | ルシフェラーゼ酵素活性を保護するための方法及びキット |
| US7829347B2 (en) * | 2005-08-31 | 2010-11-09 | Kimberly-Clark Worldwide, Inc. | Diagnostic test kits with improved detection accuracy |
| AU2007217765A1 (en) * | 2006-02-21 | 2007-08-30 | Nanogen, Inc. | Methods and compositions for analyte detection |
| US10067149B2 (en) * | 2012-12-12 | 2018-09-04 | Promega Corporation | Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer |
| KR102292431B1 (ko) * | 2012-12-12 | 2021-08-20 | 프로메가 코포레이션 | 세포내 생물발광 공명 에너지 전이를 이용하여 생물활성제에 의한 세포 표적 결합의 인식 |
| ES2926463T3 (es) * | 2013-03-15 | 2022-10-26 | Promega Corp | Activación de la bioluminiscencia mediante complementación estructural |
| JP6814132B2 (ja) * | 2014-09-12 | 2021-01-13 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | 内部タンパク質タグ |
| WO2016127100A1 (en) * | 2015-02-05 | 2016-08-11 | Promega Corporation | Luciferase-based thermal shift assays |
| WO2017143323A1 (en) * | 2016-02-19 | 2017-08-24 | Insight Instruments, Inc. | Assay systems for point of care detection of ocular analytes |
| WO2017189751A1 (en) * | 2016-04-26 | 2017-11-02 | The University Of Utah Research Foundation | Target-binding activated split reporter systems for analyte detection and related components and methods |
| US11327072B2 (en) * | 2017-02-09 | 2022-05-10 | Promega Corporation | Analyte detection immunoassay |
| JP6990369B2 (ja) * | 2017-05-19 | 2022-02-03 | 国立大学法人 熊本大学 | 遺伝性腎疾患アルポート症候群治療薬に係る評価系 |
-
2020
- 2020-04-10 SG SG11202110773RA patent/SG11202110773RA/en unknown
- 2020-04-10 AU AU2020272037A patent/AU2020272037B2/en active Active
- 2020-04-10 CA CA3135195A patent/CA3135195A1/en active Pending
- 2020-04-10 US US16/845,802 patent/US20200386748A1/en not_active Abandoned
- 2020-04-10 CN CN202080040317.1A patent/CN113891895A/zh active Pending
- 2020-04-10 BR BR112021020354A patent/BR112021020354A2/pt unknown
- 2020-04-10 JP JP2021559761A patent/JP7645812B2/ja active Active
- 2020-04-10 WO PCT/US2020/027711 patent/WO2020210658A1/en not_active Ceased
- 2020-04-10 EP EP20788198.8A patent/EP3953374A4/en active Pending
- 2020-04-10 KR KR1020217036614A patent/KR20220007058A/ko active Pending
-
2021
- 2021-10-07 IL IL287261A patent/IL287261A/en unknown
-
2025
- 2025-03-04 JP JP2025033971A patent/JP2025133108A/ja active Pending
- 2025-03-06 US US19/072,777 patent/US20250264464A1/en active Pending
-
2026
- 2026-02-26 AU AU2026201457A patent/AU2026201457A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3953374A4 (en) | 2023-06-07 |
| AU2020272037B2 (en) | 2025-11-27 |
| JP7645812B2 (ja) | 2025-03-14 |
| CN113891895A (zh) | 2022-01-04 |
| JP2025133108A (ja) | 2025-09-10 |
| US20200386748A1 (en) | 2020-12-10 |
| AU2020272037A1 (en) | 2021-12-02 |
| BR112021020354A2 (pt) | 2021-12-14 |
| CA3135195A1 (en) | 2020-10-15 |
| WO2020210658A1 (en) | 2020-10-15 |
| SG11202110773RA (en) | 2021-10-28 |
| AU2026201457A1 (en) | 2026-03-19 |
| KR20220007058A (ko) | 2022-01-18 |
| JP2022526013A (ja) | 2022-05-20 |
| US20250264464A1 (en) | 2025-08-21 |
| EP3953374A1 (en) | 2022-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287261A (en) | Compounds and methods for detecting analytes using bioluminescence | |
| IL265396A (en) | Methods and compositions for detecting analytes | |
| GB201919029D0 (en) | Method of detecting an analyte | |
| PL3138489T3 (pl) | Zestaw do określania stężenia analitu | |
| SG11202112680XA (en) | Rapid aneuploidy detection | |
| EP3321677A4 (en) | Blood test kit and analysis method using same | |
| GB202007911D0 (en) | Analyte detection method | |
| EP3927838A4 (en) | METHODS AND COMPOSITIONS FOR THE EARLY DETECTION OF CANCER | |
| EP3741857A4 (en) | DETERGENT FOR SPOTS DERIVED FROM THE CORNEAL LAYER, AND METHOD OF EVALUATING THE ABILITY TO DEGRADE SPOTS DERIVED FROM THE CORNEAL LAYER | |
| EP4063514A4 (en) | MEASURING METHOD USING ANTI-IMMUNOCOMPLEX ANTIBODIES | |
| IL290969B2 (en) | Equal-probability defect detection | |
| IL307286B2 (en) | Methods and reagents for IL-33 quantification | |
| EP3473715A4 (en) | CATALAS INHIBITOR AND METHOD FOR MEASURING ANALYTES USING THE CATALAS INHIBITOR | |
| EP3147371A4 (en) | Novel method for detecting detection object in sample, and detection kit using same | |
| EP3593122A4 (en) | METHOD OF DETECTION OF ANALYTES | |
| IL291075B1 (en) | Compositions and methods for detecting and removing interferences in a sample | |
| EP4058810A4 (en) | DEVICE AND METHOD FOR ANALYTE DETECTION | |
| AU2019405977B2 (en) | Compositions and methods for detecting Plasmodium species nucleic acid | |
| EP3112864A4 (en) | Urine sample analysis method and reagent kit for urine sample analysis | |
| EP3767294A4 (en) | REAGENT KIT, MEASUREMENT KIT AND MEASUREMENT PROCEDURE | |
| GB202104190D0 (en) | Compositions and methods for detecting group b streptococcu nucleic acid | |
| GB201902630D0 (en) | Analyte detection method | |
| GB202206029D0 (en) | Analyte detection method and device | |
| EP3112863A4 (en) | Method for urine sample analysis, reagent for urine sample analysis, and reagent kit for urine sample analysis | |
| EP3112862A4 (en) | Method for urine sample analysis, reagent for urine sample analysis, and reagent kit for urine sample analysis |